Sign in

CIK 0001125345

  • Non-accelerated filer
  • Smaller reporting company

MACROGENICS INC

Sign in to watch
Ticker
MGNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-251-5172
Business address
9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-03-04 Risser Eric Blasius Chief Operating Officer Exercise or conversion · Employee stock option (right to buy) −500 0
2022-02-22 Spitznagel Thomas Sr VP, Technical Ops Grant or award · Employee stock option (right to buy) +140,000 140,000
2022-02-22 Risser Eric Blasius Chief Operating Officer Grant or award · Employee stock option (right to buy) +170,000 170,000
2022-02-22 Peters Jeffrey Stuart Senior VP and General Counsel Grant or award · Employee stock option (right to buy) +70,000 70,000
2022-02-22 Peters Jeffrey Stuart Senior VP and General Counsel Grant or award · Restricted Stock Unit +35,000 35,000
2022-02-22 Koenig Scott President and CEO Grant or award · Employee stock option (right to buy) +480,000 480,000
2022-02-22 Karrels James SVP, CFO and Secretary Grant or award · Employee stock option (right to buy) +140,000 140,000
2022-02-22 Eck Stephen L. Chief Medical Officer Grant or award · Employee stock option (right to buy) +150,000 150,000
2022-02-22 Cilinski Lynn VP, Controller and Treasurer Grant or award · Employee stock option (right to buy) +63,400 63,400
2022-02-22 Bonvini Ezio Sr VP, Research & CSO Grant or award · Employee stock option (right to buy) +75,000 75,000
2022-02-22 Bonvini Ezio Sr VP, Research & CSO Grant or award · Restricted Stock Unit +37,500 37,500
2021-11-19 BIOTECH TARGET N V 10% owner Purchase +200,000 $18.50 $3.7M 7,275,564
2021-11-16 Bonvini Ezio Sr VP, Research & CSO Exercise or conversion +2,540 $16.00 $41K 111,090
2021-11-16 Bonvini Ezio Sr VP, Research & CSO Exercise or conversion · Employee stock option (right to buy) −2,540 0
2021-09-29 BIOTECH TARGET N V 10% owner Purchase +100,000 $20.47 $2.0M 7,075,564
2021-09-28 BIOTECH TARGET N V 10% owner Purchase +100,000 $20.64 $2.1M 6,975,564
2021-09-17 BIOTECH TARGET N V 10% owner Purchase +200,000 $19.93 $4.0M 6,875,564
2021-09-16 BIOTECH TARGET N V 10% owner Purchase +400,000 $20.94 $8.4M 6,675,564
2021-07-16 Spitznagel Thomas Sr VP, BPD & Manufacturing Exercise or conversion +5,000 $7.51 $38K 5,000
2021-07-16 Spitznagel Thomas Sr VP, BPD & Manufacturing Sale −5,000 $25.01 $125K 0

Page 22 of 26 · 503 trades